Blog

30 Aug 2023

Cognex goes deeper into Japanese market with $275M acquisition

29 Aug 2023

Apellis to lay off 225 amid shaky drug launch

29 Aug 2023

Embattled Intarcia drug licensed to Harvard spinout, with Intarcia CEO Kurt Grav...

29 Aug 2023

New England Law settles over improper federal student loan claims

29 Aug 2023

Women-led VC firm Converge aims to raise $50M for 3rd fund

29 Aug 2023

Walpole Mall sold for $72M to local real estate firm, investor

29 Aug 2023

Lowell-based nonprofit business accelerator expands to Arizona, California and T...

29 Aug 2023

Substance-use treatment startup Better Life Partners completes $26.5M Series B f...

29 Aug 2023

Nvidia, RA Capital invest in new Boston AI drug discovery company

29 Aug 2023

Crowley joins forces with Morgan Stanley to develop Salem offshore wind ports

29 Aug 2023

Good News Tuesday: Rockland Trust support Cardinal Cushing Centers

28 Aug 2023

Generics of Vyvanse, Takeda’s ADHD drug, get FDA green light